BBIO
BridgeBio Pharma, Inc. · NASDAQ
68.08
-4.30 (-5.94%)
2026-09-15 17:00:29 UTC
BBIO (BridgeBio Pharma, Inc.) is trading at 68.08, down 5.94% on the session. This page shows the live price, the session range and key statistics. Data updated 2026-09-15 17:00:29 UTC.
Key statistics
Open
72.26
Day high
72.41
Day low
67.64
Volume
1.8M
52w high
93.42
52w low
48.78
Avg vol 10d
1.9M
Market cap
13.3B
EPS
-3.57
Company profile
BridgeBio Pharma, Inc.BridgeBio Pharma, Inc. (BBIO) operates in the biotechnology industry within the health technology sector and is domiciled in United States. The company reports 839 employees. Trailing revenue is 502.1M with net income of -724.9M. Market capitalisation stands at 13.3B.
Sector
Health Technology
Industry
Biotechnology
Country
United States
Employees
839
Market cap
13.3B
Float shares
175.1M
Beta (1y)
0.12
Next earnings
29 Oct 2026
Revenue (TTM)
502.1M
Net income (TTM)
-724.9M
Gross margin
94.12%
Operating margin
-67.01%
EPS (TTM)
-3.57
52-week high
93.42
52-week low
48.78
Avg volume (10d)
1.9M



